Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgia Ritchie

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Asia-Pacific Journal of Clinical Oncology|January 20, 2018
Treatment-related toxicities of immune checkpoint inhibitors in advanced cancers: A meta-analysisJohnathan Man, Georgia Ritchie, Matthew Links, et al.
JAMA Oncology|February 23, 2018
Defining the Most Appropriate Primary End Point in Phase 2 Trials of Immune Checkpoint Inhibitors for Advanced Solid Cancers: A Systematic Review and Meta-analysisGeorgia Ritchie, Harry Gasper, Johnathan Man, et al.
JAMA Network Open|September 8, 2020
Validation of Progression-Free Survival Rate at 6 Months and Objective Response for Estimating Overall Survival in Immune Checkpoint Inhibitor Trials: A Systematic Review and Meta-analysisPeey-Sei Kok, Doah Cho, Won-Hee Yoon, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Asia-Pacific Journal of Clinical Oncology|January 20, 2018
Treatment-related toxicities of immune checkpoint inhibitors in advanced cancers: A meta-analysisJohnathan Man, Georgia Ritchie, Matthew Links, et al.
JAMA Oncology|February 23, 2018
Defining the Most Appropriate Primary End Point in Phase 2 Trials of Immune Checkpoint Inhibitors for Advanced Solid Cancers: A Systematic Review and Meta-analysisGeorgia Ritchie, Harry Gasper, Johnathan Man, et al.
JAMA Network Open|September 8, 2020
Validation of Progression-Free Survival Rate at 6 Months and Objective Response for Estimating Overall Survival in Immune Checkpoint Inhibitor Trials: A Systematic Review and Meta-analysisPeey-Sei Kok, Doah Cho, Won-Hee Yoon, et al.
Pageof 1